News

Kowa’s K-911 Advances to FDA Review for Glaucoma

Following confirmation of the PDUFA target action date of April 30, 2027, Kowa anticipates a US commercial launch of the K-911 glaucoma eye drop in the second half of 2027, subject to FDA approval.